Elizabeth Colleran

Elizabeth Colleran serves as a key procurement professional within the Defense Threat Reduction Agency (HDTRA1), supporting the agency’s mission to counter weapons of mass destruction through technical acquisition and research-driven contracting. She manages complex contracts for advanced scientific research, threat detection systems, and operational support technologies, primarily focused on chemical, biological, radiological, nuclear, and high-yield explosive defense capabilities. Her work directly enables the agency’s strategic priorities in threat intelligence, forensic analysis, and rapid response innovation, ensuring that cutting-edge R&D solutions are efficiently transitioned from laboratory to field deployment. Colleran maintains sustained partnerships with leading technical and scientific contractors including TECHTRANS INTERNATIONAL INC, BATTELLE MEMORIAL INSTITUTE, AERIS LLC, APPLIED RESEARCH ASSOCIATES, INC., and AMAZON WEB SERVICES, INC. These relationships reflect a preference for high-capacity, mission-critical vendors with deep expertise in defense science, systems engineering, and cloud-based analytical platforms. Her procurement approach emphasizes long-term collaboration with organizations capable of delivering classified, high-integrity research and development services under stringent security and compliance protocols. Her contracting portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects a mission-driven focus on technical capability over socioeconomic classifications, prioritizing domain expertise and proven performance in high-stakes national security environments. While small business participation is not formally incentivized, vendors of all sizes are evaluated solely on technical merit, past performance, and ability to meet HDTRA1’s rigorous operational requirements. The agency’s procurement activity is exclusively concentrated under NAICS 541715—Research and Development in the Physical, Engineering, and Life Sciences—underscoring a singular focus on advanced scientific R&D. Colleran’s acquisitions support the development of detection sensors, modeling and simulation tools, forensic analysis platforms, and secure data infrastructure, all critical to neutralizing evolving WMD threats through innovation-driven defense solutions.